Causes

What causes cerebral palsy?

CP results from a disruption to normal brain development, and the timing of that disruption is what determines the classification used in diagnosis:

• Prenatal causes — disruptions to brain formation in the womb, including maternal infections (rubella, cytomegalovirus, toxoplasmosis), placental insufficiency, or genetic and metabolic factors affecting fetal brain development.
• Perinatal causes (during birth) — oxygen deprivation (birth asphyxia), prolonged or obstructed labor, or emergency delivery complications that injure the developing brain.
• Postnatal causes (after birth) — neonatal infections such as meningitis or encephalitis, severe jaundice left untreated, or head trauma in early infancy.
• Prematurity and low birth weight — the single largest risk factor; underdeveloped brain structures in premature infants are significantly more vulnerable to bleeding and injury.

Why the cause and CP type matter for treatment planning

Cerebral palsy isn’t one uniform condition — spastic, dyskinetic, ataxic, and mixed CP each involve different areas and mechanisms of brain injury, and current stem cell research spans several of these subtypes with varying levels of evidence behind each (see Scientific References). The cause of injury (e.g., hypoxic injury vs. infection-driven injury) also affects which regenerative mechanisms are most relevant — this is part of why a full diagnostic work-up (see Diagnosis) precedes any treatment discussion at Viezec, rather than a single generic protocol being offered to every case.

Related reading: How Stem Cell Therapy Works for the general mechanism, or see Brain Injury if the case involves an acquired injury outside the CP classification.

Symptoms

What are the symptoms of cerebral palsy?

Symptoms vary widely depending on which areas of the brain and body are affected, and severity ranges from barely noticeable to significantly limiting. The most common signs, often first noticed by parents or pediatricians during early development, include:

• Delayed motor milestones — late sitting, crawling, standing, or walking compared to typical developmental timelines.
• Abnormal muscle tone — either spasticity (stiff, tight muscles) or hypotonia (unusually loose, “floppy” muscles), sometimes both in different limbs.
• Poor coordination and balance — difficulty with controlled, purposeful movement (ataxia), or involuntary movements (dyskinesia).
• Abnormal posture or favoring one side of the body — often an early visual cue for parents before a formal diagnosis.
• Speech, feeding, or swallowing difficulties — from reduced control over the muscles involved in these functions.
• Associated conditions — seizures, intellectual disability, or sensory impairments occur in some but not all children with CP.

When to seek evaluation

If a child shows delayed milestones, unusual muscle tone, or asymmetric movement patterns, the next step is a pediatric neurology evaluation — not a treatment consultation. See Diagnosis below for what that work-up typically involves. Early identification matters because rehabilitation started earlier in a child’s development tends to have more to work with, given how much neuroplasticity is still available in a young brain.

Diagnosis

How is cerebral palsy diagnosed?

CP diagnosis is clinical first, then confirmed with imaging — there’s no single blood test that identifies it. At Viezec, a case is only considered for regenerative therapy after this evaluation is complete:

All diagnostic evaluations at Viezec are conducted under pediatric neurology and rehabilitation specialist supervision, in line with international clinical standards, before any regenerative therapy or rehabilitation program is proposed.

If your child already has recent MRI/CT results and a GMFCS classification, you can upload the reports for a free case review rather than repeating imaging unnecessarily.

Treatment

Stem Cell Treatment for Cerebral Palsy in India

Stem cell therapy for cerebral palsy uses mesenchymal stem cells (MSCs) or neural progenitor cells to target neuroinflammation and support neural repair in the areas of the brain affected by the original injury. It is delivered at Viezec’s accredited New Delhi facility as a complement to ongoing rehabilitation — not a replacement for physiotherapy, occupational therapy, or speech therapy. Eligibility is confirmed through the diagnostic work-up described under Diagnosis.

How does it work?

MSCs are being studied for several mechanisms relevant to CP:

• Neuroprotection — releasing growth factors that protect surviving neurons from further damage and support their function.
• Anti-inflammatory action — reducing chronic neuroinflammation, a known contributor to ongoing motor dysfunction in CP.
• Support for neuroplasticity — potentially improving synaptic connectivity and myelin repair, which may aid the brain’s own capacity to reorganize function.
• Reduction of oxidative stress — limiting additional cellular damage in the affected brain regions.

See Mechanism below for a fuller explanation of how these actions combine.

Who is a candidate?

Candidacy is assessed individually based on:

• Confirmed CP diagnosis via neurological exam and imaging
• GMFCS level and specific motor/functional goals
• Age (younger children generally have greater neuroplasticity, though older children and adults are evaluated case-by-case)
• Overall health and any comorbid conditions (seizure disorders, for example, are reviewed carefully during eligibility screening)

What to expect: the treatment process

1. Neurological and developmental evaluation — reviewing existing MRI, GMFCS classification, and functional history.
2. Cell selection — autologous (the patient’s own, typically bone marrow-derived) or allogeneic (donor, typically umbilical cord-derived) MSCs, chosen based on the treatment plan.
3. GMP-grade processing — isolation, expansion, and quality testing in a certified laboratory (see Delivery Methods for facility standards).
4. Administration — via intrathecal or intravenous delivery, depending on the individual protocol.
5. Structured rehabilitation follow-up — physiotherapy, occupational therapy, and periodic reassessment, since rehabilitation involvement is one of the factors that influences outcomes (see Improvements).

Most families require a similar in-country evaluation and treatment window as other regenerative programs at Viezec; see Plan Your Visit and, for international families, Medical Visa Process for logistics.

Disclaimer: Outcomes vary by age, CP type and severity, prior therapies, and rehabilitation consistency. This treatment is designed to support, not replace, existing neurological and rehabilitative care.

Delivery Methods

How Stem Cells Are Delivered for Cerebral Palsy

The delivery method used for cerebral palsy treatment affects how directly the cells can act on affected brain tissue, and the choice depends on the child’s specific condition, age, and treatment goals.

• Intrathecal delivery — cells are injected into the cerebrospinal fluid via lumbar puncture, allowing more direct access toward the central nervous system compared to a purely intravenous route.
• Intravenous (IV) delivery — cells are infused into the bloodstream, offering a lower-risk, less invasive option, often used in combination with intrathecal administration or for younger/more fragile patients.
• Combined protocols — some treatment plans use both routes across a treatment cycle, based on the specialist’s assessment of the child’s condition.

All cellular materials used at Viezec are processed in GMP-certified and ISO-compliant laboratories, with strict sterility, purity, and infection-control protocols. No embryo-derived or fetal cells are used in any protocol.

For a broader explanation of delivery routes used across regenerative medicine (not CP-specific), see Stem Cell Delivery Methods.

Our Safety & Quality Commitments

• GMP, ISO, and NABL-certified laboratory standards
• Ethically sourced cells — no embryo-derived or fetal material
• Comprehensive sterility, safety, and infection-control protocols
• Continuous neurological assessment and structured post-therapy follow-up (see Improvements and Success Rates)

Improvements & Results

Based on clinical follow-ups, many children with cerebral palsy show measurable gains in muscle tone, mobility, coordination, and functional independence after therapy, tracked through structured neurological and physiotherapy assessments (see Diagnosis for the GMFCS baseline these are measured against).

Improved Muscle Control & Coordination

Reduced muscle stiffness and better limb coordination are among the changes most commonly reported within the first few months, often making grasping, sitting, and use of mobility aids easier.

Enhanced Mobility & Balance

Better postural control, gait stability, and endurance during physical activity are frequently reported, contributing to greater independence in daily tasks.

Improved Daily Functioning

Follow-up evaluations often show gains in speech clarity, cognitive engagement, and fine motor skills alongside the physical improvements above.

Patient Experiences

(Parent quotes carried forward from the existing page — consider adding verification, e.g. linked video testimonials, per the note under Testimonial below.)

“My child’s muscle stiffness has reduced significantly. She can sit longer without support and her hand movements are much more controlled than before.” — Parent, Delhi, India

“After therapy, my son’s balance and walking confidence improved. He now takes more steps on his own and interacts more actively during physiotherapy.” — Parent, Dubai, UAE

Consult Our Specialists

Mechanism of Action: How Stem Cells Support Neuroregeneration in Cerebral Palsy

Rather than replacing damaged brain cells directly, stem cells used in CP treatment act as biological repair agents — releasing neuroprotective molecules, modulating inflammation, and supporting conditions favorable to the brain’s own repair processes.

• Neural repair and regeneration — supporting repair of injured neurons and formation of new neural connections relevant to motor and cognitive function.
• Anti-inflammatory action — reducing chronic brain inflammation, a known contributor to motor dysfunction and ongoing tissue damage in CP.
• Neuroprotective support — secreting growth factors that protect surviving neurons and enhance neuroplasticity.
• Reduction of oxidative stress — limiting oxidative injury that can otherwise impair motor and cognitive development.

These combined actions are the basis for current research into mesenchymal stem cells (MSCs) for cerebral palsy specifically. All procedures at Viezec follow strict clinical protocols for safety and ethical sourcing throughout.

Related: for the broader science behind how MSCs work across conditions (not CP-specific), see How Stem Cell Therapy Works and Stem Cell Healing Potential.

Our Promise

Viezec’s regenerative treatment programs for cerebral palsy are built around scientifically structured therapy, personalized rehabilitation planning, and realistic expectations — not overstated outcomes. In practice, this means:

• No cure claims. CP results from existing brain injury; we do not market stem cell therapy as a cure, only as a researched, supportive option.
• Evaluation before treatment. No protocol is proposed without the neurological, imaging, and developmental evaluation described under Diagnosis.
• Named, credentialed oversight. Every treatment plan is reviewed by pediatric neurology and rehabilitation specialists. (Add the treating specialist’s name/credentials here directly — same recommendation as on other treatment pages, and the single highest-trust addition available.)
• Regulatory transparency. Our protocols operate within India’s guidelines for investigational stem cell use; we disclose which framework applies to your child’s specific treatment when asked.
• Accredited facilities. GMP, ISO, and NABL-certified laboratory standards — (insert actual accreditation registration numbers here, verifiable through each body’s public registry, as recommended on the infertility page rewrite — this is a sitewide fix, not page-specific).
• Written cost estimates. No flat public pricing, because cost varies by case — a written estimate follows your child’s evaluation, before any commitment.
• Honest evidence communication. Where evidence is still evolving — as it is for CP — we say so directly and cite the specific studies our approach draws on (see Scientific References), rather than implying stronger proof than currently exists.

Learn More About Cerebral Palsy Treatment

Treatment Results

Families pursuing stem cell therapy for cerebral palsy at Viezec often report better muscle tone regulation, enhanced motor coordination, reduced spasticity, improved balance, and greater ease with daily activities. Progress varies based on CP severity, motor impairment type, age at treatment, and overall health.

Follow-up uses standardized functional scales — GMFCS, GMFM, and muscle tone assessments — to track clinical progress and guide rehabilitation planning. Timelines differ by patient, but many families report noticeable functional gains within 6–12 months of treatment.

Viezec does not claim guaranteed results or a cure. Response depends on individual neurodevelopmental factors, CP type, and rehabilitation involvement — treatment outcomes vary from patient to patient, and current evidence remains research-driven rather than a settled standard of care.

Discuss Your Case

Testimonials

Ananya R. – Bangalore, India – Mar 2020 – ⭐⭐⭐⭐☆
“My daughter struggled with muscle stiffness from cerebral palsy. After Viezec’s stem cell therapy, her movements became smoother, and she can now grasp objects better.”

Daniel P. – London, UK – Oct 2020 – ⭐⭐⭐⭐⭐
“We saw real improvement in our son’s speech and balance. Viezec’s team guided us with care, and within months his daily activities became easier.”

Aisha K. – Riyadh, Saudi Arabia – May 2021 – ⭐⭐⭐⭐☆
“Cerebral palsy limited my child’s independence. Post treatment at Viezec, muscle tightness reduced and walking improved. A wonderful experience for our family.”

Priya S. – Mumbai, India – Dec 2021 – ⭐⭐⭐⭐⭐
“Stem cell therapy gave my son better motor control. We are amazed at how he now participates in school activities with more confidence.”

Oliver M. – Sydney, Australia – Jun 2022 – ⭐⭐⭐⭐☆
“My daughter’s coordination improved after stem cell treatment at Viezec. She smiles more now and enjoys playing with friends without constant fatigue.”

Fatima Z. – Cairo, Egypt – Nov 2022 – ⭐⭐⭐⭐⭐
“Our child’s spasticity reduced considerably after therapy. The Viezec doctors were professional and compassionate, giving us hope for continued progress.”

Miguel R. – Madrid, Spain – Feb 2023 – ⭐⭐⭐⭐☆
“Viezec’s treatment helped my son stand more steadily. His posture improved, and daily physiotherapy became more effective after stem cell therapy.”

Emily W. – Toronto, Canada – Aug 2023 – ⭐⭐⭐⭐⭐
“We noticed big changes in our daughter’s speech clarity and hand movement. The therapy at Viezec made her more independent in daily life.”

Hassan A. – Dubai, UAE – Jan 2024 – ⭐⭐⭐⭐☆
“Our little boy could barely walk before treatment. Six months after Viezec’s therapy, he takes steps with support and shows real progress every day.”

Read in Detail »

Sophia L. – Paris, France – May 2025 – ⭐⭐⭐⭐⭐
“Stem cell therapy gave our child new abilities we never thought possible. At Viezec, the care and expertise brought hope and visible improvement in her mobility.”

Read in Detail »

Treatment Disclaimer

(Existing disclaimer content is strong and well-scoped — keep largely as-is. One small addition below.)

The content on this page discusses cerebral palsy and management approaches for informational and educational purposes only. It is not a substitute for professional pediatric, neurological, or rehabilitative medical consultation. Every child’s motor challenges, developmental course, and therapy response are unique — general descriptions here may not fully apply to your specific situation.

Viezec facilitates medically guided services based on current research and clinical expertise but does not guarantee specific functional outcomes. All treatment and rehabilitation decisions should be made with a qualified pediatric neurologist or rehabilitation specialist familiar with your child’s medical history.

• What this page does: Explains CP types, causes, management strategies, and realistic expectations, with citations to the underlying research.
• What this page does not do: Replace individualized medical advice or an in-person developmental and motor assessment.
• If symptoms suddenly change: Seek prompt evaluation from a pediatric neurologist, or emergency care if urgent concerns arise.

Request Medical Evaluation